Company: SNWV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050280
Chunk: 39

Company: SANUWAVE Health, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
)- (20,657)Balances as of September 30, 20243,150,062$3 $178,397 $(238,673)$10 $(60,263)

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

6

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

(In thousands, except share data)

Nine Months Ended September 30, 2025Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulatedDeficit  Accumulated Other Comprehensive Income Total Balances as of December 31, 20248,543,686$9 $238,685 $(251,421)$10 $(12,717)Stock-based compensation4,787- 3,630 - - 3,630 Stock options exercised25,167- 375 - - 375 Shares granted in lieu of board of director fees2,524- 77 - - 77 Net income-- - 5,704 - 5,704 Balances as of September 30, 20258,576,164$9 $242,767 $(245,717)$10 $(2,931)

Nine Months Ended September 30, 2024Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulatedDeficitAccumulated Other Comprehensive Income (Loss)TotalBalances as of December 31, 20233,041,492$3 $176,979 $(220,049)$(111)$(43,178)Shares issued for settlement of warrants14,440- 6 - - 6 Shares issued for settlement of debt94,130- 1,412 - - 1,412 Foreign currency translation adjustment-- - - 121 121 Net loss-- - (18,624)- (18,624)Balances as of September 30, 20243,150,062$3 $178,397 $(238,673)$10 $(60,263)

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

7

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONS